ARMISTICE CAPITAL, LLC - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$4,734,000
+317.1%
1,800,000
+260.0%
0.28%
+21.4%
Q1 2017$1,135,000
-87.1%
500,000
-81.0%
0.23%
-91.7%
Q3 2016$8,817,000–2,632,000–2.83%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders